8 November 2021 - Man & Science announced today that it has been granted a breakthrough device designation by the Center of Devices and Radiological Health of the FDA for its minimally invasive innovative neuromodulation therapy for the treatment of chronic cluster headache.

Under the Program, the FDA will provide the Man & Science’s Occipital nerve field stimulation system with priority review and interaction with FDA’s experts throughout the premarket review phase.

Read Man & Science press release